Use access key #2 to skip to page content.
$1.05 -0.03 (-2.78%)
10/15/2008 3:54 PM

Simulations Plus, Inc. (SLP)

CAPS Rating:
**

The Company currently offers four software products for pharmaceutical research: ADMET Predictor/ ADMET Modeler, ClassPharmer, DDDPlus, and GastroPlus.

View Ticker Page (SLP)

Results 1 - 4 of 4 :   1

Recs

0

Avatar billbu (98.61) Submitted: 9/11/07 1:59 PM : Outperform Start Price: $6.30 SLP Score: -44.30

SLP's primary business is developing and producing best in class molecular modeling software for pharmaceutical discovery and development. The ability to predict the properties of proposed molecules allows researchers to avoid wasting time and resour...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar darkgoody (58.48) Submitted: 11/26/07 12:36 PM : Outperform Start Price: $5.58 SLP Score: -43.80

Lots of room for industry consolidation and decent cash-on-hand to explore acquisitions. Organic growth will continue and execution of acquisition strategy should make this a multibagger. Buy under $5.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar doublet83 (36.70) Submitted: 9/25/07 6:34 PM : Underperform Start Price: $8.50 SLP Score: 46.35

Market overestimating the addressable market of their product. Valuation can only be justified if historical growth rates are sustained for a significant period of time, but these growth rates are clearly unsustainble.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar wolfofwallstreet (83.67) Submitted: 9/05/07 6:23 PM : Outperform Start Price: $6.74 SLP Score: -45.28

Impressive revenue growth. Since the same quarter one year prior, revenues leaped by 71.0%.Earnings growth of 133.33% and other important driving factors, SLP has surged by 254.89% over the past year, outperforming the rise in the S&P 500 Index duri...

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners